|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-2-7
|
|
pubmed:abstractText |
Current labeling practices for allergenic foods like peanut can be inadequate. For future regulatory and industry guidelines, information on no-observed-adverse-effect levels (NOAELs) and eliciting doses (EDs) for allergenic foods is necessary.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0091-6749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
117
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
448-54
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16461147-Adolescent,
pubmed-meshheading:16461147-Arachis hypogaea,
pubmed-meshheading:16461147-Child,
pubmed-meshheading:16461147-Child, Preschool,
pubmed-meshheading:16461147-Dose-Response Relationship, Immunologic,
pubmed-meshheading:16461147-Double-Blind Method,
pubmed-meshheading:16461147-Female,
pubmed-meshheading:16461147-Humans,
pubmed-meshheading:16461147-Immunoglobulin E,
pubmed-meshheading:16461147-Male,
pubmed-meshheading:16461147-No-Observed-Adverse-Effect Level,
pubmed-meshheading:16461147-Peanut Hypersensitivity,
pubmed-meshheading:16461147-Placebos,
pubmed-meshheading:16461147-Questionnaires,
pubmed-meshheading:16461147-Skin Tests
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children.
|
|
pubmed:affiliation |
Department of Dermatology/Allergology, University Medical Center, Utrecht, The Netherlands. a.e.flinterman@umcutrecht.nl.
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
